Hematology, Transfusion and Cell Therapy

ISSN: 2531-1379

Hematology, Transfusion and Cell Therapy is a quarterly scientific publication of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE), Eurasian Hematology Oncology Group (EHOG), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).

Hematology, Transfusion and Cell Therapy publishes original articles, review articles and case reports covering various areas in the field of hematology and hemotherapy. The journal was previously published, until 2016, as Revista Brasileira de Hematologia e Hemoterapia.

ISSN print: 2531-1379
ISSN online: 2531-1387

Published by Elsevier Editora Ltda, Rio de Janeiro, Brazil.

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), PubMed Central (PMC), Emerging Sources Citation Index (ESCI), SCImago Journal Rank (SJR), SNIP

Ahead of print

Ahead of print are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info

First report of perioperative iptacopan interruption in paroxysmal nocturnal hemoglobinuria without breakthrough hemolysis

Katsuhiro Tokuda, Tatsuki Morioka, Shoya Arai, Takuji Matsuo, Kensuke Matsumoto, Ryosuke Shirasaki, Jun Ooi, Haruko Tashiro

10.1016/j.htct.2025.106235

Full text access

Uncorrected Proof. Available online 4 December 2025

Twitter

Facebook

Assessment of the neutrophil-to-lymphocyte ratio as a prognostic marker in patients with newly diagnosed diffuse large B-cell lymphoma: A Colombian Cohort Study

Paula María Sánchez, Juan Felipe Combariza-Vallejo

10.1016/j.htct.2025.106237

Full text access

Uncorrected Proof. Available online 1 December 2025

Twitter

Facebook

Comment on “Risk factors associated with the use of red blood cells in elective cardiac surgeries”

Hinpetch Daungsupawong, Viroj Wiwanitkit

10.1016/j.htct.2025.106236

Full text access

Uncorrected Proof. Available online 1 December 2025

Twitter

Facebook

Efficacy and safety analysis of the use of ibrutinib associated with rituximab for the first-line treatment of patients with chronic lymphocytic leukaemia

Aline do Nascimento, Daniel da Silva Pereira Curado, Thais Montezuma, Wallace Breno Barbosa, Juliana Machado-Rugolo, Mariana Millan Fachi

10.1016/j.htct.2025.106234

Full text access

Uncorrected Proof. Available online 1 December 2025

Twitter

Facebook

Functional capacity in sickle cell disease: A pilot study with 1-minute sit-to-stand test

Michele Barroso Thomaz, Lucas Fernandes Suassuna, Júlia Campos Fabri, Isabela de Oliveira Araújo, Júlia Carneiro Almeida, Daniela de Oliveira Werneck Rodrigues

10.1016/j.htct.2025.106230

Full text access

Uncorrected Proof. Available online 1 December 2025

Twitter

Facebook

Mechanistic insights into the antiproliferative effect of the redox-active iron chelator Dp44mT on multiple myeloma cell lines

Aarti Sharma, Latha Pathangey, Sinto Sebastian Chirackal, Kiran K. Mangalaparthi, Akhilesh Pandey, Rafael Fonseca, Sundararaman Swaminathan

10.1016/j.htct.2025.106233

Full text access

Uncorrected Proof. Available online 1 December 2025

Twitter

Facebook

In patients with suspected thrombotic thrombocytopenic purpura, what is the optimal time to therapeutic plasma exchange?

Alexandre Soares Ferreira Junior, Kate Sanborn, Morgana Pinheiro Maux Lessa, Alexander Gordee, Maragatha Kuchibhatla, Allison O. Taylor, Matthew S. Karafin, Oluwatoyosi A. Onwuemene

10.1016/j.htct.2025.106223

Full text access

Uncorrected Proof. Available online 27 November 2025

Twitter

Facebook

Cold-stored platelets: A systematic review of recovery in healthy adults and chest drain output in cardiothoracic surgery patients

Caleb Keane, Heba Sharif, Denise Jackson

10.1016/j.htct.2025.106226

Full text access

Uncorrected Proof. Available online 26 November 2025

Twitter

Facebook

National multiple myeloma cohort: Gaps and opportunities for research in Brazil

Diogo Moreira do Amaral

10.1016/j.htct.2025.106229

Full text access

Uncorrected Proof. Available online 26 November 2025

Twitter

Facebook

Plasma levels of soluble podoplanin are higher in acute promyelocytic leukemia compared to other forms of acute myeloid leukemia

Carla Roberta Peachazepi Moraes, Camilla Maria de Alencar Saraiva, Ivanio Teixeira Borba-Junior, Bruno Kosa Lino Duarte, Paula Melo de Campos, Sara Teresinha Olalla Saad, Erich Vinicius De Paula

10.1016/j.htct.2025.106227

Full text access

Uncorrected Proof. Available online 26 November 2025

Twitter

Facebook

Page 1 2 3 Next

Publish in

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.

Indexed in:

Follow us:

Ahead of print

Subscribe to our newsletter